Pandemic vaccines - The legal landscape

New England Journal of Medicine

Volumn 362, Issue 21, 2010, Pages 1949-1952

  Parmet, Wendy E ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VACCINE;

DRUG MANUFACTURE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFLUENZA; PANDEMIC; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

EID: 77952780918     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1000938     Document Type: Short Survey

References (5)

1. McNeil DG. 3 Rulings find no link to autism in a mercury preservative in vaccines. New York Times. March 13, 2010:A11.
2. Fisher BL. Politics, profits, and pandemic fear mongering. Vienna, VA: National Vaccine Information Center, May 1, 2009. (Accessed May 7, 2010, at http://www.nvic.org/NVIC-Vaccine-News/May-2009/Friday,-May-01,-2009-Politics, -Profits-Pandemic-.aspx.)
3. Duchin JS. The Spring 2009 influenza A H1N1 outbreak: a local public health perspective. In: Institute of Medicine, Forum on Microbial Threats, Board on Global Health. The domestic and international impacts of the 2009-H1N1 influenza A pandemic: global challenges, global solutions. Washington, DC: National Academies Press, 2009:Appendix A3. (Accessed May 7, 2010, at http://www.nap.edu/catalog/12799.html.)
4. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360:1981-1988
5. The Model State Emergency Health Powers Act. Legislative surveillance table. Baltimore: The Center for Law and the Public's Health at Georgetown and Johns Hopkins Universities, July 15, 2006. (Accessed May 7, 2010, at http://www.publichealthlaw.net/MSEHPA/MSEHPA%20Surveillance.pdf.)